INTERNATIONAL PATENT: ORION CORPORATION FILES APPLICATION FOR "2-PHENOXY-1-(4-(ALKYLSULFONYL)PIPERIDIN-1-YL)ETHAN-1-ONE AND 3-PHENYL-1-(4-(ALKYLSULFONYL)PIPERIDIN-1-YL)PROP-2-EN-1-ONE DERIVATIVES AS GPR183 ANTAGONISTS FOR THE TREATMENT OF CHRONIC PAIN"

GENEVA, Jan. 13 -- ORION CORPORATION (Orionintie 1FI-02200 Espoo) filed a patent application (PCT/FI2024/050372) for "2-PHENOXY-1-(4-(ALKYLSULFONYL)PIPERIDIN-1-YL)ETHAN-1-ONE AND 3-PHENYL-1-(4-(ALKYLSULFONYL)PIPERIDIN-1-YL)PROP-2-EN-1-ONE DERIVATIVES AS GPR183 ANTAGONISTS FOR THE TREATMENT OF CHRONIC PAIN" on Jul 04, 2024. With publication no. WO/2025/008574, the details related to the patent application was published on Jan 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AHLMARK, Marko (c/o ORION CORPORATIONP.O.Box 65FI-02101 Espoo), HAIKARAINEN, Anssi (c/o ORION CORPORATIONP.O.Box 65FI...